Interleukin-17 and interleukin-22 promote tumor progression in human nonmelanoma skin cancer. (Q38930857)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25487261%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Interleukin-17 and interleukin-22 promote tumor progression in human nonmelanoma skin cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25487261%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

0 references

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25487261%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Cristina Albanesi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25487261%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Lavinia Nardinocchi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25487261%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Giulio Sonego

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25487261%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Francesca Passarelli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25487261%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Simona Avitabile

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25487261%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Claudia Scarponi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25487261%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Stefano Simoni

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25487261%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Andrea Cavani

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25487261%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

language of work or name

English

0 references

publication date

16 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25487261%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

24 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25487261%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25487261%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25487261%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

922-931

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25487261%20AND%20SRC:MED&resulttype=core&format=json

The risk of progression to invasive disease

24 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

The epidemiology of UV induced skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

The immune score as a new possible approach for the classification of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

Immune Enhancement of Skin Carcinogenesis by CD4+ T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

The human cutaneous squamous cell carcinoma microenvironment is characterized by increased lymphatic density and enhanced expression of macrophage-derived VEGF-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

Molecular link mechanisms between inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

Interleukin-17 family members and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

The biological functions of T helper 17 cell effector cytokines in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

Cytokine mediators of Th17 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

Th17 cells in cancer: help or hindrance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

Up for Mischief? IL-17/Th17 in the tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

Recent advances in IL-22 biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

IL-17 amplifies human contact hypersensitivity by licensing hapten nonspecific Th1 cells to kill autologous keratinocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

Autocrine IL-8 and VEGF mediate epithelial-mesenchymal transition and invasiveness via p38/JNK-ATF-2 signalling in A549 lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR signaling cascade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

NF-kappaB: linking inflammation and immunity to cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

Microenvironmental regulation of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

Cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

IL-17 enhances tumor development in carcinogen-induced skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

CD8(+) T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

Enrichment of regulatory T cells in invasive breast tumor correlates with the upregulation of IL-17A expression and invasiveness of the tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

21 January 2018

Nonmelanoma skin cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

7 January 2021

Nonmelanoma skin cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

7 January 2021

Interleukin-17 promotes angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

7 January 2021

STAT3 signal transduction through interleukin-22 in oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

7 January 2021

Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

7 January 2021

Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

7 January 2021

IL-17, an important prognostic factor and potential therapeutic target for breast cancer?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445052

7 January 2021